ClearColi competent cells are a genetically modified E.coli strain that disables the offending endotoxin signal that is normally part of the lipopolysaccharide while still retaining competency and protein expression capability.
RCT has partnered with Lucigen to commercialize the ClearColi technology. Find out more about ClearColi Kits and strains available from Lucigen for virtually endotoxin-free protein and DNA production.
Lucigen has a license from RCT to sell ClearColi kits for non-commercial research purposes only. A separate license is required for any commercial use. Licenses are available from RCT. Learn more about licensing options